Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. (EUCR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EUCR · as of Jun 9, 2026
Key Statistics
Explore Eucrates Biomedical Acquisition Corp. Data
eucr stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
eucr competitorsEUCR
ARTEU
BRACU
BYTSW
FMIV
FNVTStock Performance
Full HistoryAbout Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity …
what is eucrates biomedical acquisition corp. · eucr stock overview · eucrates biomedical acquisition corp. company profile · who is eucrates biomedical acquisition corp. ceo · eucr NASDAQ · eucrates biomedical acquisition corp. headquarters · eucrates biomedical acquisition corp. business segments
About Stock Overview & Key Data
Eucrates Biomedical Acquisition Corp. (EUCR) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Dec 28, 2020. As of the latest trading session, EUCR stock price is $10.04, with a market capitalization of $42.2M. The stock has returned +1.62% over the past 12 months and +0.50% year-to-date.
In fiscal year 2022, Eucrates Biomedical Acquisition Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Eucrates Biomedical Acquisition Corp. (EUCR) stock price is $10.04. The stock is traded on NASDAQ under the ticker symbol EUCR. The 52-week range is $9.87 – $10.25.